Market Research Logo

Global Uterine Fibroids Market: Industry Analysis & Outlook (2017-2025)

Global Uterine Fibroids Market: Industry Analysis & Outlook (2017-2025)

Fibroids are tumors in the uterus which can vary in sizes depending upon the condition and level. A woman may have one or many fibroids in reproductive organ. It is common for a woman to have multiple fibroid tumors which are non-cancerous in nature. Uterine fibroids are broadly classified into four categories i.e. Subserosal fibroids, Intramural fibroids, Submucosal fibroid, and Pedunculated submucosal fibroid.

Currently, the uterine fibroid market has no definitive FDA approved agents for medical treatment of uterine leiomyomata or uterine fibroids. Gonadotropin-releasing hormone analogues (GnRHa) agents are being used to reduce size of tumor, reduce blood loss and to correct the ensuing iron-deficiency anemia.

The global uterine fibroids drugs market is expected to experience robust growth post the launch of therapeutic drugs, primarily due to increasing patient base, rise in female population, and increasing healthcare expenditure. However, the market growth is hindered by high R&D costs and regulatory warnings.

The report “Global Uterine Fibroids Drugs Market: Industry Analysis & Outlook (2017-2025)” analyzes the development of this market, with focus on the US and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: AbbVie, Myovant Sciences, Astra Zeneca, and Neurocrine Biosciences are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global uterine fibroids market along with the study of the regional markets.


1. Market Overview
1.1 Uterine Fibroids
Figure 1.1: Types and Location of Uterine Fibroids
1.2 Types of Uterine Fibroids
1.3 Symptom & Causes
1.4 Treatment & Diagnosis
Figure 1.2: Potential Phase III Drug Candidates
2. Global Uterine Fibroids Therapeutic Market Analysis
2.1 Global Uterine Fibroids Therapeutics Market Forecast by Value
Figure 2.1: Global Uterine Fibroids Therapeutics Market Forecast by Value (2016-2025)
2.2 Global Uterine Fibroids Therapeutics Market Forecast by Region
Figure 2.2: Global Uterine Fibroids Therapeutics Market Forecast by Region (2025)
2.3 Global Uterine Fibroids Therapeutics Market Forecast by Drugs
Figure 2.3: Global Uterine Fibroids Therapeutics Market Forecast by Drugs (2021)
Figure 2.4: Global Uterine Fibroids Therapeutics Market Forecast by Drugs (2025)
2.3.1 Global Lupron Market Forecast by Value
Figure 2.5: Global Lupron Market Forecast by Value (2016-2025)
2.3.2 Global Elagolix Market Forecast by Value
Figure 2.6: Global Elagolix Market Forecast by Value (2019-2025)
2.3.3 Global Relugolix Market Forecast by Value
Figure 2.7: Global Relugolix Market Forecast by Value (2021-2025)
3. Regional Uterine Fibroids Market Analysis
3.1 The US
3.1.1 The US Uterine Fibroids Therapeutics Market by Value
Figure 3.1: The US Uterine Fibroids Therapeutics Market by Value (2016-2025)
3.1.2 The US Uterine Fibroids Therapeutics Market by Drugs
Figure 3.2: The US Uterine Fibroid Therapeutics Market by Drugs (2021)
Figure 3.3: The US Uterine Fibroid Therapeutics Market by Drugs (2025)
3.1.3 The US Lupron Market Forecast by Value
Figure 3.4: The US Lupron Market Forecast by Value (2016-2025)
3.1.4 The US Elagolix Market Forecast by Value
Figure 3.5: The US Elagolix Market Forecast by Value (2019-2025)
3.1.5 The US Relugolix Market Forecast by Value
Figure 3.6: The US Relugolix Market Forecast by Value (2021-2025)
3.2 Europe
3.2.1 Europe’s Uterine Fibroids Market Forecast by Value
Figure 3.7: Europe’s Uterine Fibroids Market Forecast by Value (2016-2025)
3.2.2 Europe’s Uterine Fibroids Market Forecast by Drugs
Figure 3.8: Europe’s Uterine Fibroids Market Forecast by Drugs (2025)
3.2.3 Europe’s Lupron Market Forecast by Value
Figure 3.9: Europe’s Lupron Market Forecast by Value (2016-2025)
3.2.4 Europe’s Elagolix Market Forecast by Value
Figure 3.10: Europe’s Elagolix Market Forecast by Value (2023-2025)
3.2.5 Europe’s Relugolix Market Forecast by Value
Figure 3.11: Europe’s Relugolix Market Forecast by Value (2022-2025)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Female Population Worldwide
Figure 4.1: Global Female Population (2012-2016)
4.1.2 Rising Spending on Public Health Programs for Female
4.1.3 Growing Uterine Fibroids Market in Emerging Economies
4.1.4 Increased Spending on Medicines
Figure 4.2: Global Spending on Medicines (2010-2020E)
Figure 4.3: Total Spending on Medicines in the US (2012-2016)
4.1.5 Increasing Global Healthcare Expenditure
Figure 4.4: Global Healthcare Expenditure (2012-2016)
4.2 Trends and Developments
4.2.1 Development of New Drugs
Table 4.1: Major Drugs for Uterine Fibroids in their Development Phases (2016)
4.2.2 Increasing Demand for Minimally Invasive Surgeries
4.2.3 Expansion of More Efficient and Advanced Technology
4.3 Issues and Challenges
4.3.1 FDA’s Black Box Warnings
4.3.2 High R&D Costs
4.3.3 Drug Progress Challenges in Developing Countries
5. Competitive Landscape
5.1 Revenue and Market Cap
Figure 5.1: Market Cap & Revenue Comparison by Major Players (2016)
6. Company Profiles
6.1 AbbVie
6.1.1 Business Overview
Figure 6.1: Abbvie Revenue Share by Pharmaceutical Products (2015)
6.1.2 Financial Overview
Figure 6.2: Abbvie Revenue and Net Income (2012-2015)
6.1.3 Business Strategies
Figure 6.3: Abbvie Research and Development Expenditure (2015)
6.2 AstraZeneca
6.2.1 Business Overview
Figure 6.4: AstraZeneca Revenue by Segment (2015)
6.2.2 Financial Overview
Figure 6.5: AstraZeneca’s Revenue (2012-2015)
6.2.3 Business Strategies
Table 6.1: AstraZeneca’s Approvals and Upcoming Drugs (2015)
6.3 Neurocrine Biosciences
6.3.1 Business Overview
Figure 6.2: Clinical Pipeline of Neurocrine Biosciences (2016)
6.3.2 Financial Overview
Figure 6.6: Neurocrine Biosciences Revenue and Net Loss (2011-2015)
6.3.3 Business Strategies
6.4 Myovant Sciences Ltd. (Roivant Sciences, Ltd.)
6.4.1 Business Overview
Figure 6.3: Myovant Sciences Ltd. Product Pipeline (2016)
6.4.2 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report